Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dna X (SONM) EPS (Basic) (2018 - 2025)

Dna X filings provide 8 years of EPS (Basic) readings, the most recent being $8.14 for Q4 2025.

  • On a quarterly basis, EPS (Basic) fell 77.07% to $8.14 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.6, a 89.22% decrease, with the full-year FY2025 number at -$11.0, changed 0.0% from a year prior.
  • EPS (Basic) hit $8.14 in Q4 2025 for Dna X, up from -$4.83 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $35.5 in Q4 2024 to a low of -$9.32 in Q3 2024.
  • Median EPS (Basic) over the past 5 years was -$0.34 (2021), compared with a mean of $1.1.
  • The widest YoY moves for EPS (Basic): up 11193.75% in 2024, down 7866.67% in 2024.
  • Dna X's EPS (Basic) stood at -$0.36 in 2021, then surged by 108.33% to $0.03 in 2022, then plummeted by 1166.67% to -$0.32 in 2023, then skyrocketed by 11193.75% to $35.5 in 2024, then plummeted by 77.07% to $8.14 in 2025.
  • The last three reported values for EPS (Basic) were $8.14 (Q4 2025), -$4.83 (Q3 2025), and -$0.79 (Q2 2025) per Business Quant data.